Please login to the form below

Not currently logged in
Email:
Password:

patients

This page shows the latest patients news and features for those working in and with pharma, biotech and healthcare.

NICE says no to rival Alnylam and Akcea amyliodsis drugs – but deal could be done

NICE says no to rival Alnylam and Akcea amyliodsis drugs – but deal could be done

the body and cause polyneuropathy and cardiomyopathy which shorten a patient’s life.

Latest news

More from news
Approximately 203 fully matching, plus 5,596 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 86 fully matching, plus 685 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 444 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 213 fully matching, plus 852 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics